APA (7th ed.) Citation

Gharibkandi, N. A., Wawrowicz, K., Majkowska-Pilip, A., Żelechowska-Matysiak, K., Wierzbicki, M., & Bilewicz, A. (2023, October). Au@109Pd core–shell nanoparticle conjugated to trastuzumab for the therapy of HER2+ cancers: Studies on the applicability of 109Pd/109mAg in vivo generator in combined β− auger electron therapy. EJNMMI Radiopharmacy and Chemistry.

Chicago Style (17th ed.) Citation

Gharibkandi, Nasrin Abbasi, Kamil Wawrowicz, Agnieszka Majkowska-Pilip, Kinga Żelechowska-Matysiak, Mateusz Wierzbicki, and Aleksander Bilewicz. "Au@109Pd Core–shell Nanoparticle Conjugated to Trastuzumab for the Therapy of HER2+ cancers: Studies on the Applicability of 109Pd/109mAg in Vivo Generator in Combined β− Auger Electron Therapy." EJNMMI Radiopharmacy and Chemistry Oct. 2023.

MLA (9th ed.) Citation

Gharibkandi, Nasrin Abbasi, et al. "Au@109Pd Core–shell Nanoparticle Conjugated to Trastuzumab for the Therapy of HER2+ cancers: Studies on the Applicability of 109Pd/109mAg in Vivo Generator in Combined β− Auger Electron Therapy." EJNMMI Radiopharmacy and Chemistry, Oct. 2023.